Longevity Receives $316,000 Grant to See if Its Nerve-cell-protecting Therapy Will Work in MS
News
Longevity Biotech has received a $316,384 grant from the National MS Society to see if LBT-3627, the nerve cell-protecting therapy it has tested in Parkinson’s, can work in multiple sclerosis as well. ... Read more